Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
A novel TaqMan real-time PCR assay to estimate ex vivo human immunodeficiency virus type 1 fitness in the era of multi-target (pol and env) antiretroviral therapy.
Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study.
Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial.
Selection of drug-resistant HIV-1 mutants in response to repeated structured treatment interruptions.
Viral dynamics during structured treatment interruptions of chronic human immunodeficiency virus type 1 infection.
Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity.
Prevalence of HIV protease mutations on failure of nelfinavir-containing HAART: a retrospective analysis of four clinical studies and two observational cohorts.
Viral evolution during structured treatment interruptions in chronically human immunodeficiency virus-infected individuals.
[Resistance to protease inhibitors].
HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection.